Exploring the therapeutic effect of human recombinant IL11 on lesioned OA human osteochondral explants.

Arthritis Res Ther · 2025 · PMC11761764 · PMID 39856704

Europe PMC DOI

hedged sentence

0.2250

closest p · 4.5× alpha

0.2250

boldest claim

The sentences

showed a trendP-value = 2.25 × 10 − 1not close (p > 0.1)

However, Mankin scores of lesioned osteochondral explants treated with hrIL11 showed a trend towards lower scores (β=-0.75, P-value = 2.25 × 10 − 1 ).

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.